The Task Force the “(nano) TiO₂ safety communication” was initiated by Damjana Drobne (University of Ljubljana, Slovenia) and aims to adequately and accurately cover the scientific findings regarding TiO₂ and TiO₂ nano safety and to provide independent and transparent scientific opinion and advice to stakeholders. The selection criteria for available studies will be applied to find the best available in vivo and in vitro evidence; the latter might serve to understand underlying mechanisms.

The deliverables will include a report to be published in a scientific journal on recent evidence on genotoxicity, mutagenicity and carcinogenicityof TiO₂ considering inhalation, as well as oral and dermal route of exposure. Information will be collected from NSC/ EU funded projects as well as from recent publications in the scientific literature and  recent publically available reports. An opinion on the CLH for TiO₂ dossier to ECHA, EFSA, NIA, CEPE, TDMA will also be delivered and (generic) guidelines for nano-safty state of the art to be used by  regulators (REACH and CLH regulation). The Task Force will also try to propose a scheme for communicating scientific evidence regarding nanomaterial safety findings in the most efficient and transparent way.

The work of this task force was featured in March 2018 in an article written by science editor, of Chemical Watch: Global Risk & Regulation News, Andrew Turley on “Poorly soluble, low toxicity particles facing review“.

The Task Foce launched in January 2018 and ended in February 2020. Further details can be found here.

The slides from the relevant TF webinar can be found here.

Please see below for the final report of the Task Force.